Apertor Pharmaceuticals Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Apertor Pharmaceuticals is a biotechnology research company based in South San Francisco, California. It is developing a new class of therapeutics aimed at selectively disrupting disease-causing protein-protein interactions. The approach hinges on Interceptors that induce proximity with a protein naturally abundant in cancer cells, enabling the disruption of harmful protein complexes. Through its synthetic biology platform, the company seeks to advance proprietary Interceptors that could unlock new treatment options for cancer patients.

In oncology research and development, its target customers include scientists and biopharma partners pursuing new ways to treat cancer through innovative protein-interaction mechanisms. By focusing on selective disruption of disease-causing PPIs, Apertor situates itself in the biotechnology research sector that explores next-generation cancer therapeutics. The company is small and based in South San Francisco, reflecting its integration into California’s biotech community.

Sign up for free to view info

Company overview Employee directory